LA JOLLA PHARMACEUTICAL CO Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 10.92 | 85 | 928 | 85 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 9.28 | 85 | 789 | 79,117 | 79 K to 79.1 K (+0.11 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 10.92 | 171 | 1,867 | 171 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 9.28 | 171 | 1,587 | 3,786 | 3.6 K to 3.8 K (+4.73 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 10.92 | 171 | 1,867 | 171 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 9.28 | 171 | 1,587 | 2,513 | 2.3 K to 2.5 K (+7.30 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 10.92 | 62 | 677 | 62 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 9.28 | 62 | 575 | 6,341 | 6.3 K to 6.3 K (+0.99 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.57 | 196 | 1,876 | 196 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.13 | 196 | 1,593 | 3,615 | 3.4 K to 3.6 K (+5.73 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.57 | 196 | 1,876 | 196 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.13 | 196 | 1,593 | 2,342 | 2.1 K to 2.3 K (+9.13 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.57 | 70 | 670 | 70 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.13 | 70 | 569 | 6,279 | 6.2 K to 6.3 K (+1.13 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.57 | 98 | 938 | 98 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.13 | 98 | 797 | 79,032 | 78.9 K to 79 K (+0.12 %) |